Characteristics | Univariate OR (95% CI)a | P-value | Multivariate OR (95% CI)a | P-value |
---|---|---|---|---|
Exposure period | ||||
Pre-COVID-19 | Reference | |||
COVID-19 Year 1 | 1.11 (1.02, 1.21) | 0.02 | 1.05 (0.96, 1.15) | 0.33 |
COVID-19 Year 2 | 1.34 (1.23, 1.46) | < 0.001 | 1.17 (1.06, 1.28) | 0.01 |
Rate of 1st and 2nd trimester gestational weight gain (kg/week) | 1.07 (0.95, 1.21) | 0.3 | 1.31 (1.15, 1.49) | < 0.001 |
Maternal age at conception | ||||
< 20 years | 0.34 (0.20, 0.56) | < 0.001 | 0.39 (0.23, 0.66) | < 0.001 |
20–24.9 years | 0.49 (0.41, 0.59) | < 0.001 | 0.54 (0.44, 0.65) | < 0.001 |
25–34.9 years | Reference | |||
35–39.9 years | 1.64 (1.52, 1.78) | < 0.001 | 1.57 (1.44, 1.71) | < 0.001 |
40 years and over | 1.96 (1.66, 2.32) | < 0.001 | 1.92 (1.59, 2.31) | < 0.001 |
Pre-pregnancy BMI categoryb | ||||
Underweight | 0.79 (0.64, 0.97) | 0.03 | 0.84 (0.68, 1.05) | 0.12 |
Healthy weight | Reference | |||
Overweight | 1.59 (1.46, 1.72) | < 0.001 | 1.61 (1.48, 1.76) | < 0.001 |
Obese | 1.86 (1.70, 2.05) | < 0.001 | 2.10 (1.89, 2.33) | < 0.001 |
Ethnicity | ||||
Caucasian | Reference | |||
South Asian | 2.27 (2.02, 2.55) | < 0.001 | 2.24 (1.98, 2.53) | < 0.001 |
Middle Eastern | 1.54 (1.36, 1.73) | < 0.001 | 1.50 (1.32, 1.70) | < 0.001 |
East and Southeast Asian | 1.95 (1.70, 2.23) | < 0.001 | 2.14 (1.85, 2.47) | < 0.001 |
Aboriginal and Torres Strait Islander | 1.42 (1.04, 1.94) | 0.03 | 1.47 (1.05, 2.05) | 0.03 |
Socioeconomic disadvantage: SEIFA quintilec | ||||
Q1 (most disadvantaged) | 1.20 (1.05, 1.38) | 0.01 | 1.31 (1.13, 1.51) | < 0.001 |
Q2 | 1.16 (1.02, 1.320 | 0.02 | 1.06 (0.92, 1.22) | 0.41 |
Q3 | 1.10 (0.95, 1.270 | 0.21 | 1.01 (0.87, 1.18) | 0.88 |
Q4 | 0.99 (0.85, 1.16) | 0.90 | 0.85 (0.72, 1.00) | 0.05 |
Q5 (least disadvantaged) | Reference | |||
Nulliparity | 0.98 (0.92, 1.06) | 0.66 | 1.60 (1.48, 1.74) | < 0.001 |
Prior history of gestational diabetes | 6.25 (5.54, 7.06) | < 0.001 | 6.05 (5.28, 6.92) | < 0.001 |
First degree family member or sister with diabetes | 1.73 (1.62, 1.86) | < 0.001 | 1.40 (1.29, 1.50) | < 0.001 |
Polycystic ovarian syndrome | 1.60 (1.41, 1.83) | < 0.001 | 1.33 (1.15, 1.53) | < 0.001 |